Home › Biotechnology › Zoono (ASX:ZNO)

NZ$77,000 cash remains after Zoono reports NZ$736,000 quarterly receipts

Biotechnology By Ada Torres 3 min read

Zoono Group has advanced retailer, packaging and shipping-container programs across several markets, but ended the September quarter with just NZ$77,000 in cash. The company estimates funding for 0.67 quarters and says further funding lines or an equity raise may be required if customer receipts do not accelerate.

  • NZ$736,000 in quarterly customer receipts, up NZ$495,000 year on year
  • Cash falls to NZ$77,000 after NZ$115,000 operating outflow and NZ$65,000 in repayments
  • UK retailer trials across strawberries and raspberries due to begin in October
  • Shipping-container programs active with four South African exporters
  • Management cites NZ$5.2 million of inventory and possible new funding options

Cash balance drops to NZ$77,000

Zoono Group Limited (ASX:ZNO) is making tangible progress turning its shelf-life technology into commercial programs, but the September quarter left little room for delay. Cash ended at NZ$77,000, down from NZ$267,000 three months earlier, while the company’s standard cash-flow calculation showed only 0.67 quarters of funding available.

Customer receipts reached NZ$736,000 in the quarter. That was NZ$236,000 below the June quarter, but NZ$495,000 above the prior corresponding period. The improvement in receipts did not translate into positive operating cash flow: Zoono used NZ$115,000 in operations, repaid NZ$65,000 of borrowings and leases, and recorded a further NZ$10,000 foreign-exchange impact.

The company says the reported cash burn should not be treated as a steady-state forecast, pointing to signed contracts, incoming orders and NZ$5.2 million of net inventory that can be used to reduce the cash cost of goods sold. It also disclosed that further funding lines are available and that it could consider a placement or rights issue. No amount, timing or firm commitment was provided for those potential funding sources.

Retailer trials move into larger formats

The operational story is more encouraging. In the United Kingdom, regional in-store trials with three major retailers are due to start in October, covering strawberries and raspberries sourced domestically and from overseas. The programs will run for eight to 20 weeks before final rollout decisions, building on what Zoono describes as positive results from smaller trials. The UK push follows UK soft-fruit orders, which were previously valued at NZ$600,000 under an exclusive packaging contract.

South African orders under an exclusive agreement with a leading large-format corrugated packaging producer are continuing in line with the first-year volume schedule. A tomato trial with a premium retailer is planned for October or November, while completed trials of coated plastic punnets for table grapes have put Zoono on a targeted path to commercial rollout in 2027. In Australia, the company has begun direct engagement with all three major retailers after a successful soft-fruit trial and is planning a full-container carrot export trial.

Shipping-container use adds a recurring-revenue test

Through strategic partner OSY Group, Zoono products are now being used to coat containers carrying fresh produce from South Africa and Namibia. Commercial programs are in place with four South African fruit exporters, while three of the world’s largest container shipping lines have approved the products for global fleet use. Zoono says order volumes with those shipping lines remain under discussion, so the approvals represent potential reach rather than disclosed revenue.

The company is also developing applications for cut-flower sleeves and combinations with other shelf-life technologies, alongside trials in Europe and other target markets. That broadens the addressable use cases, but the immediate test is financial: whether October and November trials, existing packaging orders and shipping-container activity generate receipts quickly enough to bridge the gap between a NZ$77,000 cash balance and the next stage of commercial rollout.

Bottom Line?

Zoono’s commercial pipeline is widening, but the next two quarters must convert trials, inventory and contracts into cash before funding becomes the dominant story.

Questions in the middle?

  • Will the UK and South African retailer trials lead to rollout decisions and repeat orders within the company’s short funding window?
  • How quickly can Zoono turn its NZ$5.2 million inventory balance into customer deliveries and cash receipts?
  • Will the company secure new funding before its cash position requires a placement, rights issue or other capital measure?

Sources